124 related articles for article (PubMed ID: 7585563)
1. In vivo gene therapy with p53 or p21 adenovirus for prostate cancer.
Eastham JA; Hall SJ; Sehgal I; Wang J; Timme TL; Yang G; Connell-Crowley L; Elledge SJ; Zhang WW; Harper JW
Cancer Res; 1995 Nov; 55(22):5151-5. PubMed ID: 7585563
[TBL] [Abstract][Full Text] [Related]
2. Adenoviral-mediated gene therapy with Ad5CMVp53 and Ad5CMVp21 in combination with standard therapies in human breast cancer cell lines.
Parker LP; Wolf JK; Price JE
Ann Clin Lab Sci; 2000 Oct; 30(4):395-405. PubMed ID: 11045764
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy of malignant glioma cells with 2-5A-antisense telomerase RNA and recombinant adenovirus p53.
Komata T; Kondo Y; Koga S; Ko SC; Chung LW; Kondo S
Gene Ther; 2000 Dec; 7(24):2071-9. PubMed ID: 11223987
[TBL] [Abstract][Full Text] [Related]
4. Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus.
Liu TJ; Zhang WW; Taylor DL; Roth JA; Goepfert H; Clayman GL
Cancer Res; 1994 Jul; 54(14):3662-7. PubMed ID: 8033080
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus-mediated transfer of a wild-type p53 gene and induction of apoptosis in cervical cancer.
Hamada K; Alemany R; Zhang WW; Hittelman WN; Lotan R; Roth JA; Mitchell MF
Cancer Res; 1996 Jul; 56(13):3047-54. PubMed ID: 8674061
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus-mediated expression of p53 or p21 in a papillary serous endometrial carcinoma cell line (SPEC-2) results in both growth inhibition and apoptotic cell death: potential application of gene therapy to endometrial cancer.
Ramondetta L; Mills GB; Burke TW; Wolf JK
Clin Cancer Res; 2000 Jan; 6(1):278-84. PubMed ID: 10656459
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic effects of Ad5CMV-p53 expression in two human nasopharyngeal carcinoma cell lines.
Li JH; Li P; Klamut H; Liu FF
Clin Cancer Res; 1997 Apr; 3(4):507-14. PubMed ID: 9815713
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of tumor cell growth by p21WAF1 adenoviral gene transfer in lung cancer.
Joshi US; Chen YQ; Kalemkerian GP; Adil MR; Kraut M; Sarkar FH
Cancer Gene Ther; 1998; 5(3):183-91. PubMed ID: 9622102
[TBL] [Abstract][Full Text] [Related]
9. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T
Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054
[TBL] [Abstract][Full Text] [Related]
10. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells.
Elliott MJ; Stilwell A; Dong YB; Yang HL; Wong SL; Wrightson WR; Martin RC; McMasters KM
Cancer Gene Ther; 2002 May; 9(5):453-63. PubMed ID: 11961668
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of sensitive assays to quantitate gene expression after p53 gene therapy and paclitaxel chemotherapy using in vivo dosing in tumor xenograft models.
Wen SF; Xie L; McDonald M; DiGiacomo R; Chang A; Gurnani M; Shi B; Liu S; Indelicato SR; Hutchins B; Nielsen LL
Cancer Gene Ther; 2000 Nov; 7(11):1469-80. PubMed ID: 11129289
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck.
Liu TJ; el-Naggar AK; McDonnell TJ; Steck KD; Wang M; Taylor DL; Clayman GL
Cancer Res; 1995 Jul; 55(14):3117-22. PubMed ID: 7606733
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of chemosensitivity in human bladder cancer cells by adenoviral-mediated p53 gene transfer.
Miyake H; Hara I; Gohji K; Yamanaka K; Arakawa S; Kamidono S
Anticancer Res; 1998; 18(4C):3087-92. PubMed ID: 9713515
[TBL] [Abstract][Full Text] [Related]
14. p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin.
Huang S; Liu LN; Hosoi H; Dilling MB; Shikata T; Houghton PJ
Cancer Res; 2001 Apr; 61(8):3373-81. PubMed ID: 11309295
[TBL] [Abstract][Full Text] [Related]
15. TabBO: a model reflecting common molecular features of androgen-independent prostate cancer.
Navone NM; Rodriquez-Vargas MC; Benedict WF; Troncoso P; McDonnell TJ; Zhou JH; Luthra R; Logothetis CJ
Clin Cancer Res; 2000 Mar; 6(3):1190-7. PubMed ID: 10741751
[TBL] [Abstract][Full Text] [Related]
16. [Adenovirus-mediated p53 gene therapy of human laryngeal cancer].
Wang Q; Han D; Wang W
Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):418-21. PubMed ID: 10920932
[TBL] [Abstract][Full Text] [Related]
17. 2-Chloroethyl-3-sarcosinamide-1-nitrosourea (SarCNU) inhibits prostate carcinoma cell growth via p53-dependent and p53-independent pathways.
Huynh H; Nguyen TH; Panasci L; Do P
Cancer; 2004 Dec; 101(12):2881-91. PubMed ID: 15529313
[TBL] [Abstract][Full Text] [Related]
18. Endogenous p21WAF1/CIP1 status predicts the response of human tumor cells to wild-type p53 and p21WAF1/CIP1 overexpression.
Kralj M; Husnjak K; Körbler T; Pavelić J
Cancer Gene Ther; 2003 Jun; 10(6):457-67. PubMed ID: 12768191
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy for bladder cancer using adenoviral vector.
Wada Y; Gotoh A; Shirakawa T; Hamada K; Kamidono S
Mol Urol; 2001; 5(2):47-52. PubMed ID: 11690547
[TBL] [Abstract][Full Text] [Related]
20. High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus.
Zhang WW; Fang X; Mazur W; French BA; Georges RN; Roth JA
Cancer Gene Ther; 1994 Mar; 1(1):5-13. PubMed ID: 7621238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]